VYNE Therapeutics IncVYNE
Price$28.56Intrinsic value$24.5014% below price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $454K-57.4% YoYTTM through 31 Mar 2026
Net Income -$3.6MTTM through 31 Mar 2026
Free Cash Flow -$25.7MTTM through 31 Mar 2026

Margins

Current
Operating Margin-4,434.9%
Net Margin-4,168.6%

Returns

-14.5%ROE
-13.8%ROA

Balance Sheet Health

Debt / Equity0.00x
Current Ratio20.86x
Net Debt-$24.9Mnet cash position
Cash & Equivalents$24.6M

Quality Metrics

FCF Margin-5,669.6%
Earnings-Beat Rate75.0%

Dividend

No dividend
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.